News
-
-
-
PRESS RELEASE
CORRECTION: Ondine Biomedical Inc. Announces Steriwave in first Swiss hospital
University Hospital Zurich initiates independent clinical study on Ondine Biomedical's Steriwave for preoperative nasal decolonization, led by Professor Dr. Dr. Harald Essig, to combat surgical site infections -
PRESS RELEASE
Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
Tolebrutinib phase 3 study in NEJM shows delayed disability progression in multiple sclerosis. Potential first therapy targeting immunologic drivers. US priority review ongoing -
-
-
-
-
-